News & Events

Press Releases

Show All

September 2009

September 14, 2009 Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity TestingDownload PDF

MADISON, Wis. and SITTINGBOURNE, Kent, England, Sept. 14, 2009– Cellular Dynamics International (CDI) and VivoMedica plc announce the launch of CARDIOTOX – a pharmaceutical industry consortium to validate a human cell model and analysis system for preclinical cardiotoxicity testing of pharmaceutical candidate compounds. The consortium will be formally launched at the Safety Pharmacology Society 9th Annual Meeting in Strasbourg, France, on Sept. 15-18, 2009, during a workshop sponsored by CDI and VivoMedica at 12:30p.m. CET on Sept. 17.